PRA Health Sciences, Inc.
PRAH
PRAH was delisted on the 30th of June, 2021.
281 hedge funds and large institutions have $6.32B invested in PRA Health Sciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 97 increasing their positions, 124 reducing their positions, and 38 closing their positions.
268% more call options, than puts
Call options by funds: $6.76M | Put options by funds: $1.84M
4% more capital invested
Capital invested by funds: $6.06B → $6.32B (+$251M)
4% less funds holding
Funds holding: 293 → 281 (-12)
22% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 124
29% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 38
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$65M |
| 2 |
Morgan Stanley
New York
|
+$41.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$41.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$36.8M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$25.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$46M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$25.3M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24.6M |
| 4 |
BlackRock
New York
|
-$20.8M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$14.4M |
PRAH Hedge Fund Activity: Q3 2020 in Review
281 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in PRA Health Sciences, Inc. (PRAH) for Q3 2020, worth a combined $6.32B — up 4.1% from $6.06B a quarter earlier.
Sellers outnumbered buyers: 38 funds closed out of PRAH and 27 opened new positions — a net loss of 11 holders — while 124 trimmed existing stakes and 97 added.
The largest buyer was Massachusetts Financial Services, adding an estimated $65M. The largest seller was Ameriprise, cutting an estimated $46M.
- 281 institutional investors held PRA Health Sciences, Inc. (PRAH) as of Q3 2020, down from 293 in Q2 2020.
- Funds reported $6.32B of PRA Health Sciences, Inc. stock for Q3 2020, up 4.1% quarter-over-quarter.
- 27 funds opened new PRA Health Sciences, Inc. positions in Q3 2020 and 38 closed out, a net change of -11 holders.
- The largest PRA Health Sciences, Inc. buyer in Q3 2020 was Massachusetts Financial Services, an estimated $65M added.
- The largest PRA Health Sciences, Inc. seller in Q3 2020 was Ameriprise, an estimated $46M sold.
Based on aggregated 13F filings for Q3 2020.